Advanced Blood Management in Total Joint Arthroplasty (EP Video)
Dr. Doug G. Nuelle discusses his approach to advanced blood management in total knee arthroplasty (43:55 minutes).
World's Largest Resource for Cardiovascular Perfusion
Dr. Doug G. Nuelle discusses his approach to advanced blood management in total knee arthroplasty (43:55 minutes).
This randomized, controlled trial demonstrates that point‐of‐care guided and prophylactic treatment with fibrinogen concentrate does not reduce transfusion of blood products in a setting of unexpectedly low transfusion rate as tested in this cohort, but may improve coagulation parameters in the setting of high‐risk cardiac surgery.
The authors provide a visual representation of the coagulation pathways that distinguishes between the steps involved in thrombosis and hemostasis to explain why factor XI inhibitors may serve as hemostasis-sparing anticoagulants. A safer class of anticoagulants would provide opportunities for treatment of a wider range of patients, including those at high risk for bleeding. Ongoing clinical studies will determine the extent to which factor XI inhibitors attenuate thrombosis without disruption of hemostasis.